Navigation Links
Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
Date:10/10/2007

eart palpitations, weakness, shortness of breath and angina (chest pain).(3)

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at http://www.astellas.com/us.

References

(1) Arrhythmias Originating in the Atria. American Heart Association:

http://www.americanheart.org/presenter.jhtml?identifier=10. Accessed

July 10, 2007.

(2) Miyasaka Y, Barnes ME, Gersh BJ, et al. American Heart Association:

http://circ.ahajournals.org/cgi/content/abstract/114/2/119?etoc.

Accessed June 28, 2007.

(3) Mayo Clinic. Atrial fibrillation. Available at:

http://www.mayoclinic.com/health/atrial-fibrillation/DS00291. Accessed

October 26, 2006.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... its board of directors has received a preliminary non-binding ... Zhang , chairman of the board of directors of ... investment vehicle wholly owned by Mr. Zhang(" Neptunus Holding ...
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/3/2015)... , July 4, 2015 ... epidemics of hypertension, diabetes and thyroid disorders in Central ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2
... Pharmion,Corporation (Nasdaq: PHRM ) and ... of the first patient in a Phase ... Companies, isotype-selective histone,deacetylase inhibitor (HDACi) product candidate, ... DNA demethylating agent,in patients with relapsed or ...
... Semafore Pharmaceuticals Inc.,today announced that a paper ... 1: 206-215) reports that SF1126, the company,s ... The paper, entitled "A Vascular Targeted ... and Antiangiogenic Activity," is,based on preclinical studies ...
Cached Medicine Technology:Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 2Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 3Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 4Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 5Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 6Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma 7Semafore's SF1126 Exhibits Antitumor and Antiangiogenic Activity 2
(Date:7/6/2015)... ... 06, 2015 , ... Dr. Lawrence Green is now offering the newly FDA-approved ... is a non-surgical method to dissolve fat cells and is the first of its ... under the chin, commonly known as a double chin. Dr. Green participated in clinical ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and the Glycemic ... have diabetes, the majority of which are Type 2. However, eight million do not ... in three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar ...
(Date:7/5/2015)... ... July 06, 2015 , ... ... is excited to announce the next generation of PrimeStar Individual Dental Insurance. Beginning ... now include two network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable ...
(Date:7/5/2015)... Philadelphia, PA (PRWEB) , ... July 05, 2015 ... ... engineer of patented products, announces the Weed Master, a landscaping invention that ... is worth $75 billion US dollars," says Scott Cooper, CEO and Creative Director ...
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire ... the best online millionaire dating service and strives to remove the worries from meeting ... 1 millionaire dating app of 2015 and readers have responded with excitement. ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2
... service (EMS) providers in the United States assess ... Only 5 to 10 percent of people who ... cardiopulmonary resuscitation (CPR) provided by prehospital EMS providers ... The Resuscitation Outcomes Consortium (ROC) is the largest ...
... as 34 weeks, potentially adding to preemie delivery rate, experts say ... the rate of preterm deliveries continues to climb in the United ... women are confused about what constitutes a full-term birth in the ... study considered a baby born at 34 to 36 weeks of ...
... flu , FRIDAY, Nov. 20 (HealthDay News) -- Canadian ... to develop severe cases of H1N1 flu than seasonal flu. ... for admission with pandemic H1N1 influenza, present in 21 percent ... Allen and fellow researchers from the Hospital for Sick Children ...
... ... Services Task Force. These guidelines may be cost-effective, but they come at the price of ... ... published in the current issue of the Annals of Internal Medicine, has set off a ...
... , , SPRINGFIELD, Mo., Nov. 20 ... Missouri regions will now have the option to choose ... between Missouri Consolidated Health Care Plan (MCHCP) and Mercy ... regions include the following counties: Barry, Barton, Cedar, Christian, ...
... , , LOS ... African American Families, The Wall/Las Memorias, Latina Breast Cancer Agency, ... today sent a letter to Blue Shield of California calling ... , The letter to Blue Shield specifically calls for an ...
Cached Medicine News:Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: